Drug Utilization Evaluation of imipenem and intravenous ciprofloxacin in a teaching hospital

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue SUPPL., 2013, Pages 157-163

  Mousavi, Sarah ^a   Behi, Mehdi ^b   Taghavi, Mohammad Reza ^b   Ahmadvand, Alireza ^c   Ziaie, Shadi ^d   Moradi, Mandana ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ciprofloxacin; Drug utilization evaluation; Hospital; Imipenem

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM;

ADULT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DOSE CALCULATION; DRUG MONITORING; DRUG USE; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

EID: 84875200937     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Fahimi F, Baniasadi SH, Behzadnia N, Varahram F and Ghazi Tabatabaie L. Enoxaparin Utilization Evaluation: An Observational Prospective Study in Medical Inpatients. Iranian J. Pharm. Res. (2008) 7: 77-82
2. Mack SD and Demsey JW. Drug utilization: A regional approach. Leader Health Serv. (1995) 4: 34-37.
3. The Society of Hospital Pharmacists of Australia. Committee of Specialty Practice in Drug Use Evaluation. SHPA standards of practice for drug use evaluation in Australian hospitals. Aust. J. Hosp. Pharm. (1996) 26: 240-6.
4. Tavakoli-Ardakani M, Eshraghi A, Hajhossein Talasaz A and Salamzadeh J. A Drug Utilization Evaluation Study of Amphotericin B in Neutropenic Patients in a Teaching Hospital in Iran. Iranian J. Pharm. Res. (2012) 11: 151-156
5. Stolar M. Drug use review: operational defenitions. Am. J. Hosp. Pharm. (1978) 33: 225-230.
6. Lee KR, Leggiadro RJ and Burch KJ. Drug use evaluation of Antibiotics in a pediatric teaching hospital. Infect. Control. Hosp. Epidemiol. (1994) 15: 710-2.
7. Vazin A, Japoni A, Shahbazi S, Davarpanah MA. Vancomycin Utilization Evaluation at Hematology-Oncology Ward of a Teaching Hospital in Iran. Iranian J. Pharm. Res. (2012) 11: 163-170
8. Alanis AJ. Resistance to Antibiotics: Are We in the Post-Antibiotic Era? Arch Med. Res. (2005) 36: 697-705.
9. Shaw PM, Gayman JE and Todd MW. ASHP Guidelines on medication-use evaluation. Am. J. Health Syst. Pharm. (1996) 53: 1953-5.
10. McEvory G. AHFS drug information. American Society of Health System Pharmacists (2011) 177, 357.
11. Collaborating Center for Drug Statistics Methodology. ATC Index with DDDs. The WHO Collaborating Center, Oslo, Norway. (2000)
12. Raveh D, Muallem-zilcha E, Greenberg A, Wiener-well Y, Schlesinger Y and Yinnon AM. Prospective drug utilization evaluation of three broad-spectrum antimicrobials: cefepime, piperacillin-tazobactam and meropenem. Q. J. Med. (2006) 99: 397-406.
13. Charles Flacy, Armstrong L, Goldman M P and Lance L. Drug information hand book with international trade names apha. Lexicomp (2008-2009): 344, 815.
14. Takhar P, Yadav S, Dua S and Mahant S. Investigation of antibiotic usage pattern: A prospective drug utilization review. Der. Pharmacia. Lettre. (2011) 3: 301-306.
15. Koda-Kimble M, Yee Young L, Alldredge BK, Corelli RL, Guglielmo J, Kradjan WA and Williams BR. Applied therapeutics: the clinical use of drugs. 10th edition. Section 14: 1437.